Casdin Capital LLC Takes $5.79 Million Position in iShares Nasdaq Biotechnology ETF (IBB)

Casdin Capital LLC acquired a new stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 60,000 shares of the financial services provider’s stock, valued at approximately $5,786,000. iShares Nasdaq Biotechnology ETF accounts for approximately 1.0% of Casdin Capital LLC’s portfolio, making the stock its 27th biggest holding. Casdin Capital LLC owned about 0.08% of iShares Nasdaq Biotechnology ETF at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of the company. Morgan Stanley lifted its holdings in shares of iShares Nasdaq Biotechnology ETF by 3.7% during the third quarter. Morgan Stanley now owns 4,026,110 shares of the financial services provider’s stock worth $490,944,000 after purchasing an additional 143,209 shares during the period.